A detailed history of Wexford Capital LP transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Wexford Capital LP holds 34,879 shares of BCYC stock, worth $713,624. This represents 0.21% of its overall portfolio holdings.

Number of Shares
34,879
Previous 44,879 22.28%
Holding current value
$713,624
Previous $908,000 12.89%
% of portfolio
0.21%
Previous 0.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.58 - $27.24 $195,799 - $272,400
-10,000 Reduced 22.28%
34,879 $791,000
Q2 2024

Aug 13, 2024

BUY
$20.02 - $24.69 $200,200 - $246,900
10,000 Added 28.67%
44,879 $908,000
Q4 2023

Feb 15, 2024

BUY
$13.29 - $22.2 $463,541 - $774,313
34,879 New
34,879 $630,000

Others Institutions Holding BCYC

About BICYCLE THERAPEUTICS plc


  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $607M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Wexford Capital LP Portfolio

Follow Wexford Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Wexford Capital LP with notifications on news.